$27.60
-0.20 (-0.72%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.67%
1Y
+541.86%
YTD
+208.21%
Open$28.00
Previous Close$27.80
Day High$28.17
Day Low$26.84
52W High$31.35
52W Low$3.76
Volume—
Avg Volume955.8K
Market Cap3.54B
P/E Ratio—
EPS$-1.93
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$19.51
Above
SMA 200
$8.26
Above
RSI (14)
60.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-11.2% upside
Current
$27.60
$27.60
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.32M | 878.33M | 917.39M |
| Net Income | -367,474,748 | 120.27M | 166.79M |
| Profit Margin | -1,011.8% | 13.7% | 18.2% |
| EBITDA | -396,291,261 | 272.46M | 241.94M |
| Free Cash Flow | — | 126.96M | 147.40M |
| Rev Growth | — | +6.0% | +16.1% |
| Debt/Equity | — | 0.25 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |